News

Iovance: Amtagvi's Rocky Launch And Mounting Concerns Lead To A 'Sell' Rating
Iovance faces major setbacks with AMTAGVI's weak launch, cash burn, and scalability issues despite scientific progress. Find ...
Def Leppard's Vivian Campbell in remission after lengthy battle with Hodgkin's lymphoma
Def Leppard's Vivian Campbell is "completely clean" of cancer. The 62-year-old rocker was diagnosed with Hodgkin's lymphoma ...
CERo Therapeutics, Inc. Announces Option Exercise for Additional Series D Financing
CERo Therapeutics Holdings, Inc. (Nasdaq: CERO) (“CERo”), an innovative immunotherapy company seeking to advance the next ...
Rock Legend, 62, Shares Health Update 12 Years After Cancer Diagnosis
Def Leppard guitarist Vivian Campbell is in "complete remission" 12 years after being diagnosed with cancer. The rock icon, ...
Clinical Trials Arena on MSN14d
Diakonos Oncology secures $20m for Phase II trial of glioblastoma treatment
Diakonos Oncology has closed a $20m private placement of Simple Agreements for Future Equity (SAFE) for its Phase II trial of ...
Noise112d
Vivian Campbell of Def Leppard In Remission After Battling Hodgkin’s lymphoma
Def Leppard’s Vivian Campbell is “completely clean” of cancer. Campbell was diagnosed with Hodgkin’s lymphoma in 2013, and after taking some time out to recover from treatment, he returned to the ...
GEN - Genetic Engineering and Biotechnology News11d
Cell and Gene Therapy Leaders Tell FDA: “Believe in American Solutions”
Leaders from the world of cell and gene therapy shared their personal stories and policy recommendations in an extraordinary ...
Vietnam Investment Review on MSN14d
CARsgen showcases Satri-cel breakthroughs at ASCO 2025 and in The Lancet
The oral presentation at the 2025 ASCO Annual Meeting (Abstract 4003) was titled "Claudin18.2-specific CAR T cells (Satri-cel ...
Pharmaceutical Technology18d
Solid tumours: CAR-T therapies’ Waterloo
Expanding the reach of CAR-T therapeutics could unlock promising new treatment possibilities for solid tumour patients.